According to Dr. Reddy's's latest financial reports the company's current EPS (TTM) is $3.71. In 2022 the company made an earnings per share (EPS) of $2.71 an increase over its 2021 EPS that were of $2.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.71 | 36.88% |
2022 | $2.71 | 18.14% |
2021 | $2.29 | 34.07% |
2020 | $1.71 | 21.36% |
2019 | $1.41 | -7.1% |
2018 | $1.52 | 64.13% |
2017 | $0.93 | 7.5% |
2016 | $0.86 | -61.17% |
2015 | $2.22 | 5.97% |
2014 | $2.09 | -5.38% |
2013 | $2.21 | 46.78% |
2012 | $1.51 | -13.09% |
2011 | $1.73 | 41.17% |
2010 | $1.23 | -199.25% |
2009 | -$1.24 | -269.81% |
2008 | $0.73 | -12.82% |
2007 | $0.84 | 0.54% |
2006 | $0.83 | 301.34% |
2005 | $0.21 | 72.26% |
2004 | $0.12 | -68.7% |
2003 | $0.38 | 25.18% |
2002 | $0.31 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | 0.78% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -49.88% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -14.30% | ๐ซ๐ท France |
GlaxoSmithKline GSK | $3.50 | -5.67% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | -$2.00 | -153.89% | ๐ฎ๐ฑ Israel |